Articles tagged with Vaccination
The study found that those who received the vaccine had a significant response rate of 22.1% and progression-free survival of 2.9 months compared to 9.7% and 1.6 months respectively in those that did not. The median overall survival for those receiving vaccine trended positive at 17.6 months.
The vaccine-autism debate persists despite scientific consensus, fueled by internet misinformation and declining public trust. Pediatrician Paul Offit's efforts to set the record straight have been hindered by celebrity anti-vaccine advocates like Jenny McCarthy.
A new multimeric-L2 protein vaccine shows robust antibody responses and protection against human papillomavirus (HPV) infection in mice and rabbits. The vaccine has the potential to address the limited protection of current HPV vaccines against other HPV types, which cause cancer.
Researchers at La Jolla Institute have identified a cellular defect that increases the risk of severe reactions to the smallpox vaccine in people with eczema. Boosting Natural Killer cell activity may help prevent such reactions.
Researchers have developed a new computer simulation model that captures the human immune response to influenza type A, predicting treatment design and pandemic preparedness. The model reveals that drugs and vaccines targeting dendritic cell presentation of antigens have a significant impact on patient outcomes.
A potential vaccine for Alzheimer's disease has been shown to slow the weakening of muscles associated with inclusion body myositis (IBM) in mice. The study found reduced levels of beta amyloid and oligomeric beta amyloid, a more toxic form, in the skeletal muscle tissue.
The European Union has awarded $4 million to support the development of new antibiotics and vaccines against pneumococcal infections. Researchers from 13 international institutions are working together to combat this deadly disease, which claims over 60,000 lives annually in Germany alone.
A paper in The Lancet raises concerns about the Gates Foundation's allocation of funds, with 65% going to just 20 organizations. The authors suggest improving governance, transparency and accountability, as well as investing more in health systems and research capacity in low-income countries.
Vaccine refusal puts children at risk of infectious diseases like measles and pertussis, even if parents are vaccinated. Healthcare providers can play a critical role in explaining the benefits of immunization and addressing parental concerns.
A study by Case Western Reserve University found that vaccination records may not accurately predict a child's protection from disease, even with valid written records. Serologic testing revealed immunization levels did not consistently match those of the written records.
Identifying a transcription factor that regulates blood stem cells, researchers found ELF4 activates an inhibitor that stops naive T cells from proliferating. This discovery could lead to better vaccines and more effective cancer immunotherapy by controlling T cell growth and production.
Researchers found that after reassortment with a human influenza virus, an avian flu virus requires relatively few mutations to spread rapidly between mammals by respiratory droplets. This process is similar to the formation of the current swine flu outbreak, suggesting a potential link between avian and human influenza viruses.
A MSU researcher has developed a working vaccine for Enterotoxigenic E. coli, responsible for 60% of all E. coli diarrheal disease. The vaccine could save untold lives and also provide relief from post-operative complications such as paralytic ileus and urinary retention.
Physicians from the Catholic University of Rome assessed health conditions of 150 children living with mothers in prison. Environmental factors and early weaning are linked to premature birth, hypertension, and allergy risk. Vaccination status is also a concern, with only 14% of jail-bound children fully vaccinated.
A new study from the University of Missouri found that newborns' immune systems require time to mature before responding effectively to vaccines. This slow maturation can lead to an overabundance of Th-2 cells, which can cause allergic reactions and make infants more susceptible to infections.
Rising temperatures and mild winters have led to increased outbreaks of bluetongue and other insect-transmitted viruses in European livestock, with devastating consequences for ruminants. The UK successfully suppressed a major outbreak in 2008, but new virus types pose ongoing threats to the region.
A population-based study found that HPV16 and HPV18 genotypes were present in the majority of invasive cervical cancers in New Mexico. The mean age of women diagnosed with HPV16- or HPV18-positive cancer was 5 years younger than that of women diagnosed with other HPV types, suggesting implications for future cancer screening.
A study of nearly 218,000 children across 45 low-income and middle-income countries found significant delays in vaccination timing, with some countries experiencing delays of over 10 weeks for certain vaccines. The study highlights the need for improved vaccine coverage and timeliness to protect children from preventable diseases.
A new vaccine is being tested to prevent colon cancer by stimulating an immune response against the MUC1 protein in precancerous growths. The vaccine has shown promise in generating an immune response despite weakened immune systems, suggesting it may stop polyps from transforming into malignant tumors.
A Phase II clinical trial found that the vaccine showed efficacy in mothers, with a significantly lower rate of CMV infection. The study used an experimental vaccine made from glycoprotein B and included an adjuvant to improve immune response.
A new experimental vaccine has shown promising results in preventing cytomegalovirus (CMV) infection in infants, reducing the risk by 50% compared to a saline injection. The vaccine was given to 441 CMV-negative women and found to be safe with minimal side effects.
A new Norwegian study suggests that HPV vaccination can prevent up to 35-128 preterm births per 100,000 births by reducing the risk of surgical treatment after cervical cell changes. The vaccine may have an important impact on preventing extremely preterm births.
A study by Massachusetts General Hospital found that both Latino and non-Latino women are more likely to accept HPV vaccination for themselves and their children than previously reported. The main motivator for these women is the prevention of cancer, with no association between vaccine acceptance and income or education level.
A new strategy to enhance the BCG vaccine's effectiveness has shown superior protection against tuberculosis in a pre-clinical test. By neutralizing the bacteria's evasive mechanisms, researchers have increased the number of TB organisms killed and duration of protection by threefold.
A new study published in the Journal of Leukocyte Biology suggests that interferon can improve the effectiveness of the current tuberculosis vaccine by enhancing dendritic cell function. The research found that type I interferon stimulated dendritic cells to produce a stronger immune response against Mycobacterium tuberculosis.
Scientists at NIST developed a measurement method to quantify the slowing down of molecular rattling in preservative formulations. The team discovered a general pattern of behavior that applies to various materials, promising better preservation and extended shelf life for vaccines, food, and other biological materials.
Researchers found that HAART contributes to pulmonary hypertension in HIV-infected patients by impairing blood vessel-lining endothelial cell function. A novel treatment for chronic hypoxic pulmonary hypertension (PHTN) involves neprilysin, which protects against PHTN by regulating neural signaling molecules.
Researchers discovered how meningitis bacteria use a protein to disguise themselves as human cells, evading the immune system. This finding could lead to improved vaccines against meningitis B, which accounts for most UK cases. The bacterial protein can be modified to generate a stronger immune response.
Researchers found no increased risk of Guillain-Barré syndrome after HPV vaccination, but cases still warrant careful monitoring. The study analyzed data from the Vaccine Adverse Event Reporting System and reported 36 cases within six weeks of vaccination.
Researchers have created a new test to better predict whether a given vaccine candidate will protect or harm patients with dengue fever. The test aims to address the deadly complications associated with the disease, which affects 100 million people annually and claims 22,000 lives yearly.
Researchers find voluntary vaccination effective in containing outbreaks of diseases like smallpox and SARS due to social network effects. Neighborhood size plays a crucial role in determining the effectiveness of voluntary vaccination programs.
Despite high awareness, African-Americans are underrepresented in HPV vaccination due to misinformation, lack of education, and societal pressures. The survey found that most participants believed the vaccine was safe and effective, but caregivers were often unaware of its benefits.
A recent review summarizes studies refuting the claim of a vaccine-autism link, instead attributing symptoms to coincidental timing or other factors. Immunization rates are crucial in preventing outbreaks of vaccine-preventable diseases.
A pediatric vaccine has been found to be highly effective in preventing pneumococcal meningitis, a deadly disease that affects young children. The vaccine, PCV7, protects against seven common pneumococcal types, accounting for over 80% of cases in young children, and has been shown to decrease rates by 30-64% in both children and adults.
A new vaccine aims to treat and stop prostate cancer by targeting the unique sugar molecules expressed on cancer cells. The vaccine has shown promise in preclinical studies and could potentially be used against other types of carcinomas such as breast, lung, and ovarian cancers.
The American College of Physicians emphasizes the need for enhanced infection control practices to prevent viral hepatitis outbreaks. Researchers also stress the importance of proper antibiotic treatment for health care-associated pneumonia, highlighting its more serious nature compared to community-acquired pneumonia.
Researchers at UT School of Public Health found a strong link between PVL and severe CA MRSA infections. Using animal models, they identified PVL as a potential vaccine target against these deadly strains.
Scientists identify a common vulnerability in rotaviruses, enabling the development of a broad-spectrum treatment for severe diarrheal diseases. This breakthrough could lead to improved vaccines and medications to prevent or treat rotavirus infections.
A recent Mayo Clinic study found adults with asthma are seven times more likely to develop invasive pneumococcal diseases, a serious and potentially fatal condition. The researchers recommend including asthma as an indication for pneumococcal vaccination in adults, which could significantly reduce instances of this disease.
Experts outline three rules for selecting technological fixes, emphasizing the importance of cause-effect relationships, clear benefits, and standardized technical cores. Vaccines serve as a successful example, while literacy education highlights the challenges of finding effective solutions.
The study found that global child immunization coverage is significantly lower than reported by individual nations or WHO/UNICEF estimates. The researchers estimated the coverage of three doses of diphtheria, tetanus, and whooping cough vaccine (DPT3) based on surveys using all available data from 193 countries between 1986-2006.
A new study found that a fractional dose of a commonly used meningitis vaccine is as effective as the full dose, allowing for more efficient use of scarce vaccine resources. The research was conducted in Uganda and suggests that using 1/5 doses could be an alternative in mass vaccination campaigns during epidemics.
The high cost of childhood vaccines leads to financial strain for physicians, with prices varying widely across medical practices. Many physicians are paying too much for vaccines while receiving too little reimbursement, but new data can help improve these areas.
Researchers at Heidelberg University Hospital developed a vaccine that prevents multiple sclerosis in mice by suppressing the harmful immune response. The treatment uses autologous immune cells treated with mitomycin and expresses a self-protein from the nervous system, rendering them non-reactive to the disease.
Researchers from Cedars-Sinai Medical Center presented several studies on brain-immune interactions, including the role of cilia in regulating hippocampal neurogenesis and the use of dendritic cells to boost anti-glioma immune responses. These findings have important implications for our understanding of the brain's immune system and p...
A new study finds that accelerating the pertussis vaccine schedule by two weeks could prevent at least 1,236 cases of the disease each year. This shift would also reduce hospitalizations and deaths attributed to pertussis, a disease that can be life-threatening in young infants.
A new cancer vaccine has elicited an immune response in most patients with bowel, kidney and prostate cancer, suggesting potential clinical benefit. The vaccine, TroVax, is well-tolerated and may provide survival benefits to patients.
Researchers at Saint Louis University have identified an investigational vaccine that induces a better immune response and is more effective at protecting against tuberculosis. The vaccine uses a weakened TB germ from one of the strains of the current tuberculosis vaccine.
Researchers have developed a novel delivery system that significantly enhances vaccine effectiveness while tailoring it based on the desired type of immune response. Using RNA molecules, their system achieved immune responses five to 50 times stronger than traditional vaccines in mice studies.
Researchers at Aberystwyth University have licensed a discovery of a protein that can 'wake up' dormant Mycobacterium tuberculosis bacteria, potentially leading to the development of a more effective vaccine. The Aeras Global TB Vaccine Foundation plans to take its recombinant BCG (AERAS-407) vaccine to clinical trial in 2009.
A national survey reveals that nearly one in four parents believe vaccines cause autism, leading to fewer vaccinations and a growing number of measles infections. The study's findings highlight the lingering fear and confusion surrounding vaccines, despite overwhelming scientific evidence debunking the link.
A randomized clinical trial found that changing dosing and administration of an anthrax vaccine to intramuscular injection resulted in fewer adverse events while maintaining comparable effectiveness. The study also discovered that a reduced 3-dose schedule was noninferior to the licensed regimen.
A study of 349 children with MS and 2,941 without the disease found that hepatitis B vaccination does not increase multiple sclerosis risk. However, a specific type of vaccine was linked to symptoms in vaccinated children with MS, three or more years after vaccination.
Researchers have identified a key role for cytokine interleukin 17 in immune system detection of pneumococcus. This discovery may help develop an effective and affordable vaccine for the disease, which affects young children and the elderly.
A study by the University of Nottingham aims to identify bacterial antigens that could lead to an effective vaccine against Bovine Mastitis. The researchers will use state-of-the-art molecular technology to determine which proteins are essential for infection.
A new breast cancer vaccine has been tested in mice and shown to completely eliminate HER2-positive tumors, even those resistant to current therapy. The vaccine uses activated immunity to target the HER2 receptor, potentially eliminating the need for existing therapies.
Researchers will develop oral vaccines against tetanus and rotavirus, targeting vulnerable infants and young children. The goal is to create a vaccine that doesn't contain live bacteria and has fewer side effects.
A study published in Public Library of Science found no association between the MMR vaccine and the onset of autism or gastrointestinal symptoms in children. The study analyzed bowel tissues from 25 children with autism and GI disturbances, as well as 13 controls, and found no presence of measles virus RNA in either group.
A team of vaccine safety experts has developed a step-by-step tool to identify children with allergic reactions to vaccines and provide safe immunization plans. Most children with known or suspected vaccine allergies can be safely vaccinated with proper monitoring and precautions, according to the study.
A CMAJ study found significantly higher rates of anaphylaxis in young women after HPV vaccination, with a rate of 2.6 per 100,000 doses administered. However, the overall rates were low and no serious lasting effects were observed.